VR Logo

Natco Pharma Ltd.


Healthcare | Drugs & Pharma

we think vacations are for wimps

40 Stocks to buy right now

Join Value Research Stock Advisor now and be among the first to discover Stock Ideas

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

About The Company

Business: Manufacture of pharmaceuticals, medicinal chemical and botanical products

Incorporated: 1981

Chairman: V C Nannapaneni

Managing Director: V C Nannapaneni

Group: Natco

Listing: NSE: NATCOPHARM, BSE: 524816

Headquarters: Hyderabad, Telangana

Website: www.natcopharma.co.in

Key Facts

Market cap: R 15,742.51 Cr

Revenue (TTM): R 1,915.00 Cr

Earnings (TTM): R 458.10 Cr

Cash: R 428.20 Cr

Total Debt: R 386.30 Cr

Promoters' ownership: 48.93%

Liquidity: High

52 Week range: R 402.55 - 898.00

Face value: R2.00

Shares outstanding: 18,20,67,975

10 Years Aggregate:

  • CFO: 2,067.60 Cr
  • EBITDA: 3,513.15 Cr
  • Net Profit: 2,430.88 Cr

Stock Performance

Time Period Natco Pharma S&P BSE Healthcare S&P BSE Mid Cap
YTD42.8846.26-3.66
1 month24.7318.537.64
3 months37.9628.6226.23
1 Year53.4054.375.46
3 Years6.8115.39-0.76
5 Years11.232.334.52
10 Years36.0913.466.63
As on 10-Aug-2020
Year Natco Pharma S&P BSE Mid Cap S&P BSE Healthcare
2019-14.53-3.05-3.55
2018-29.15-13.31-5.89
201765.9148.130.49
20160.567.97-12.88
201590.607.4315.06
201488.8454.6947.43
201374.59-5.7322.55